UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 6-K

 

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of May 2022

 

Commission File Number: 001-40952

 

 

 

Babylon Holdings Limited

 

 

 

1 Knightsbridge Green

London, SW1X 7QA

United Kingdom

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x    Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Investor Presentation

 

Beginning on May 3, 2022, Babylon Holdings Limited (the “Company”) will make available presentation slides, dated May 2022, for use during investor meetings (the “Investor Presentation”). The Investor Presentation is posted on the Investor Relations page of the Company’s website at https://ir.babylonhealth.com. A copy of the Investor Presentation is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.

 

 

 

EXHIBIT INDEX

 

Exhibit    
Number   Exhibit Title
     
99.1   Investor Presentation, May 2022

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Babylon Holdings Limited
   
Date: May 3, 2022 /s/ Charlie Steel
  Charlie Steel
  Chief Financial Officer